TCF7 and neoplasm: Furthermore, multiple studies have reported that a self-renewal PD-1+ T cell population with stem cell properties that expresses TCF7 (coding for T cell factor 1) proliferates in the periphery and lymphoid organs and undergoes tumor antigen–driven expansion following anti–PD-1 therapy (79–83).